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Abstract
Background: Rheumatic diseases are a major health and financial burden for societies. The prevalence of rheumatic 
diseases may change over time, and therefore, we sought to estimate the prevalence of rheumatic diseases in an adult 
population of central Greece.
Methods: In this prospective cross-sectional population survey, a random sample of adult population was drawn from 
poll catalogues of a region in central Greece. A postal questionnaire was sent to 3,528 people for the presence of any 
rheumatic disease. All positive cases were further confirmed by clinical examination using the American College of 
Rheumatoloy criteria. Multiple regression analysis was used to assess risk factors for rheumatic diseases.
Results: The response rate was 48.3% (1,705 answers). Four hundred and twenty individuals (24.6%) had a rheumatic 
disease. The prevalence of rheumatoid arthritis was 0.58% (95% confidence interval [CI], 0.32-0.87), of psoriatic arthritis 
was 0.35% (95% CI, 0.33-1.13), of ankylosing spondylitis was 0.29% (95% CI, 0.28-0.94), of primary Sjögren's syndrome 
was 0.23% (95% CI, 0.22-0.75) and of systemic lupus erythematosus was 0.11% (95% CI, 0.11-0.37). One individual had 
systemic sclerosis (prevalence, 0.058%), 1 individual had dermatomyositis (prevalence, 0.058%; 95% CI, 0.05-0.18), 2 
individuals had vasculitis (prevalence 0.11%; 95% CI, 0.11-0.37), 81 individuals had gout (prevalence, 4.75%; 95% CI, 
4.41-5.13), and 304 individuals had osteoarthritis (OA) (prevalence 17.82%; 95% CI, 16.50-19.34). Gout was associated 
with male gender, diabetes mellitus, and hypertension, and OA was associated with age, female gender, and 
hypertension.
Conclusions: Rheumatic diseases are common in central Greece, affecting nearly a quarter of adult population. OA 
and gout are the most common joint disorders.
Background
Rheumatic diseases are a common cause of disability, and
a large public health burden [1]. However, they may vary
considerably in prevalence, mainly due to environmental
factors. For example, the prevalence of systemic lupus
erythematosus (SLE) or systemic sclerosis (SSc) differ in
ethnic populations living in different geographical
regions [2,3]. Also, the prevalence of the rheumatic dis-
eases may change over time. In a US population, the inci-
dence of rheumatoid arthritis (RA) progressively declined
since early 1960s, while the prevalence of gout doubled
from 1969 to 1985, and it further increased by 80% from
1990 to 1999 [4]. In Greece, two older studies on the
prevalence of rheumatic diseases have taken place mainly
in the north-west of the country [5,6]. Therefore, we con-
ducted a population survey for the prevalence of rheu-
matic diseases in central Greece.
Methods
A prospective two-step population-based cross-sectional
survey was conducted from April 2007 to June 2008 in
the Prefecture of Magnesia, a coastal region of central
Greece. This region consists of a mainland with plains,
mountains, and islands. The study involved a mailed
questionnaire followed by confirmation clinical examina-
tion and tests, when needed, of individuals with a positive
reply.
A sample of adults was drawn from poll catalogues of
the Prefecture of Magnesia by systematic random sam-
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pling. The study involved 3,528 subjects (2% of the total
176,433 adult population in poll catalogues), consisting of
2 %  o f  t h e  po p u l a t i o n  i n  e a c h  s u b - r e gi o n ,  u r ba n ,  ru r a l ,
highlander, and islander population. According to their
sub-region of residence, our sample consisted of 2,216
persons living in urban regions (2% of urban adult popu-
lation), 723 persons living in rural regions (2% of rural
adult population), 335 persons living in mainland high-
lands (2% of adult highlanders), and 254 persons living in
islands (2% of islander adult population). Persons who
could not be traced by mail (n = 200) were replaced using
the same randomization process.
A postal questionnaire aimed at detecting any individ-
ual with current or previous diagnosis of a rheumatic dis-
ease. An explanatory letter was sent along with the
questionnaire in a stamped self-addressed envelope to
each one of randomly selected individuals. Persons were
asked directly to report any diagnosis of: rheumatoid
arthritis (RA), psoriatic arthritis (PsA), ankylosing spon-
dylitis (AS), systemic lupus erythematosus (SLE), primary
Sjogren's syndrome (pSS), systemic sclerosis (SSc), poly-
myositis (PM), dermatomyositis (DM), gout, osteoarthri-
tis (OA), and vasculitis (e.g Do you suffer from
rheumatoid arthritis? yes or no; Do you suffer from psori-
atic arthritis? yes or no; etc). These "self-reported doctor-
diagnosed" questions seemed to provide the best estimate
for overall arthritis prevalence, with acceptable sensitivity
and specificity, according to cognitive and validation
studies [4].
The questionnaire also contained questions about
demographic and life-style variables. Social-demographic
variables included age, sex, and working status (employed
- current occupation, out of work [unemployed, early
retirement] and retirement). A qualitative score (0 and 1)
was given for the degree of mechanical stress to joints
according the particular occupation (Table 1). Lifestyle
variables included: smoking status, recorded as any cur-
rent and/or in the past daily smoking (yes) or not (no);
alcohol consumption, classified into 4 categories: no use
(no more than 3 drinks per year), light drinking (less than
2 drinks per day), moderate drinking (2-4 drinks per day)
and heavy drinking (more than 4 drinks per day). Finan-
cial and family problems were self-reported as yes/no
variables. The utilization of classical disease modifying
anti-rheumatic drugs (DMARDs) and biologics were also
recorded.
Case detection through questionnaire was followed by
case confirmation. Individuals who responded positively
for any disease item were called in for evaluation by one
rheumatologist (IA). A medical history was recorded and
a careful clinical examination was carried out. Any previ-
ous laboratory test results or imaging findings were taken
into account during the diagnostic procedure. For each
rheumatic disease, established classification criteria of
the American College of Rheumatology were used [7-15].
The study was approved by the Ethics Committee of our
Hospital. All data remained confidential.
Statistical analysis
Statistical analysis was carried out using the SPSS v.13.0
statistics package. Categorical parameters were com-
pared using the Fisher's exact test or Pearson chi-square
test. Rheumatic diseases were tested for associations with
gender, age, or other confounding parameters using uni-
variate and multivariate logistic regression analysis. Asso-
ciations were expressed in terms of unadjusted or
adjusted odds ratio (OR) with 95% confidence interval
(CI). An effect was considered significant, when p < 0.05.
Results
One thousand seven hundred and five individuals (48.3%)
(females, 54.1%; mean age ± standard deviation [SD],
51.08 ± 15.25 years) responded to questionnaire. Four
hundred and twenty individuals (24.6%) reported a rheu-
matic disease and were invited for confirmation of diag-
nosis. Diagnoses had been made by Rheumatologists at
University Hospitals, and private practice offices. All
cases were confirmed.
Ten individuals had RA (7 women, 3 men; mean age ±
SD, 46.82 ± 14.9 years; prevalence, 0.57% [95% CI, 0.32-
0.87]). Eleven individuals had spondylartropathies (SpA):
five individuals had AS (1 woman, 4 men; mean age ± SD,
43.46 ± 15.04 years; prevalence, 0.29% [95% CI, 0.28-
0.94]), and six individuals had PsA (4 women, 2 men;
mean age ± SD, 41.56 ± 2.2 years; prevalence, 0.35% [95%
CI, 0.33-1.33]). Two individuals had SLE, (prevalence,
0.11%), four individuals had pSS (prevalence 0.23%; 95%
CI, 0.22-0.75), one individuals had SSc (prevalence,
0.058%), and one individual had DM (prevalence 0.058%).
Two individuals had vasculitis (prevalence, 0.11%): one
with giant cell arteritis, and one with hypocomplement-
emic urticarial vasculitis syndrome (HUVS) (Table 2).
Eighty one individuals had gout (mean age ± SD, 63.0 ±
7.8 years; prevalence, 4.71% [95% CI, 4.41-5.13]). The
prevalence of gout was 10.0% in men and 0.3% in women.
It was 0.0% in the < 40 year-age group, 5.3% in the 40-65
year-age group and 9.6% in the > 65 year-age group. By
univariate logistic regression analysis, age, male gender,
diabetes mellitus, hypertension, smoking, and manual
work were risk factors associated with gout (Table 3).
Three hundred and four individuals had OA (mean age
± SD, 65.54 ± 12.9 years; prevalence, 17.82 [95% CI, 16.5-
19.34]). The overall prevalence in women was 12.96%
(95% CI, 11.85-14.23; mean age ± SD, 72.39 ± 8.25 years),
and in men 4.86% (95% CI, 4.35-5.43; mean age ± SD,
65.97 ± 7.57 years). The prevalence of symptomatic knee
OA (knee symptoms verified by a positive radiograph)
was 11.3% (95% CI, 9.76-13.09) in women, and 2.99%Anagnostopoulos et al. BMC Musculoskeletal Disorders 2010, 11:98
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(95% CI, 2.6-3.42) in men. Also, the prevalence of hand
OA was 0.99% (95% CI, 0.76-1.25) in women, and 0.70%
(95% CI, 0.56-0.86) in men. Finally, the prevalence of
symptomatic hip OA was 0.64% (95% CI, 0.43-0.89) in
women, and 1.17% (95% CI, 0.99-1.38) in men. By univar-
iate logistic regression analysis, age, diabetes mellitus,
hypertension, and living in island were risk factors associ-
ated with OA (Table 4).
Discussion
Our study is a population-based postal survey using a
random population sample. In Manchester, UK, a study
by questionnaire followed by examination conducted in
early 1990s, showed that the prevalence of RA was 0.3%
in blacks and 0.8% in whites [16]. In Halmstad, Sweden, a
study using a questionnaire of 3,928 persons and review
of medical records of persons who did not reply, found a
prevalence of RA to be 0.51% [17]. In Spain and Italy, the
prevalence of RA was 0.3-0.5% [18,19]. In our study, the
prevalence of RA lies between those found by a retro-
spective study (0.35%) [5] and a cross-sectional study
(0.68%) [20] in Greece.
The prevalence of AS varies according to the frequency
of HLA-B27 in the general population. It has been
reported 0.1% in African blacks and Eskimos, 0.5%-1% in
whites of the USA and UK, and 6.0% in Amerindians [21].
In a retrospective study, using medical records of a Uni-
versity hospital in northern Norway in 1990, the preva-
lence of AS was 0.21% [22]. In Ancona, Italy, a study,
using a questionnaire followed by review of medical
Table 1: Demographic and lifestyle variables included in the questionnaire
Variable Definition
Gender Male/Female
Age ≥ 50 years
Residence Urban, Rural, Highland, Island
Drinking situation No use: ≤ 3 drinks per year
Light drinker: < 2 drinks per day
Moderate drinker: 2-4 drinks per day
Heavy drinker: > 4 drinks per day
Current occupation nonmanual: clerks, small business owners, merchants, university graduates, students, artists
manual: Industry workers, construction workers, cleaning, farmers, ranchers, fishermen, transporters
Out of work: unemployed, early retired
Age retirement
Smoking status Yes: Current and/or in the past daily smoking
No: not ever daily smoking
Financial problems Yes/No
Diabetes Mellitus Yes/No
Hypertension Yes/No
Table 2: Prevalence of rheumatic diseases in central Greece
Disease Prevalence(%) Age(years) Women:men ratio
(95% CI) (mean ± SD)
Rheumatoid arthritis 0.57 (0.32-0.87) 46.8 ± 14.9 2.3: 1
Ankylosing spondylitis 0.29 (0.28-0.94) 43.5 ± 15.0 1: 4
Psoriatic arthritis 0.35 (0.33-1.33) 41.6 ± 2.2 2:1
Sjogren syndrome 0.23 (0.22-0.75)
Systemic lupus erythematosus 0.11
Systemic sclerosis 0.06
Dermatomyositis 0.06
Vasculitis 0.11
Gout 4.71 (4.41-5.13) 63.0 ± 7.8 0:8
Osteoarthritis (OA) 17.82 (16.5-19.34) 65.6 ± 7.7 2.7:1Anagnostopoulos et al. BMC Musculoskeletal Disorders 2010, 11:98
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records and examination in 2007, showed a prevalence of
AS of 0.37%, and that of SpA of 1.1% [23]. In north-west
Greece a study, using medical records of hospitals and
Rheumatology Private Practices between 1983 and 2002,
has found AS prevalence to be 0.03%, with HLA-B27 pos-
itivity present in 80.5% of patients [24]. Another study in
Greece in 2002 showed a prevalence of AS of 0.24% and
that of SpA of 0.49% [6]. In Izmir, Turkey, the prevalence
of AS was 0.49% and that of SpA was 1.05% [25].
The prevalence of PsA in a study based on medical
records in the Olmsted county, Minesota, USA in 1992
was 0.1% [4,26] and in another study conducted by phone
in a random US population sample was 0.25% [27]. In the
latter study, the prevalence of psoriasis was 2.2% [27]. In
western Norway, a study using medical records of Rheu-
matology centers covering 442,000 persons between 1999
and 2002, found the prevalence of AS to be 0.19% [28]. In
Ancona, Italy, a study using questionnaire in 2007 showed
Table 3: Variables assessed for association with gout
Variable Gout Unadjusted OR P-value Adjusted OR
Yes No (95% CI) 95% c.i.
Gender Male 10.0% 90.0% 33.926
(10.664-107.932)
<0.01 25.873
(7.811-85.699)
Female 0.3% 99.7%
Age ≥66 9.6% 90.4% Non-applicable <0.01
≥40 & <66 5.3% 94.7%
<40 0.0% 100.0%
Residence Island 6.2% 93.8% 1.446
(0.805-2.599)
0.346 1.107
(0.580-2.113)
Mountain 6.1% 93.9% 1.016
(0.433-2.384)
0.738
(0.296-1.839)
Urban and suburban 4.4% 95.6% Reference Reference
Alcohol Yes 7.8% 92.2% 3. 357
(2.060-5.471)
<0.01 1.654
(0.819-3.342)
No 2.5% 97.5%
Smoke Yes 7.4% 92.6% 2.589
(1.633-4.105)
<0.01 1.035
(0.540-1.984)
No 3.0% 97.0%
Financial problems Yes 4.0% 96.0% 0.799
(0.490-1.305)
0.400 0.842
(0.489-1.450)
No 5.0% 95.0%
Manual work Yes 6.5% 93.5% 1.680
(1.040-2.713)
0.044 0.973
(0.569-1.664)
No 3.9% 96.1%
Diabetes mellitus Yes 11.1% 88.9% 2.972
(1.711-5.161)
<0.01 2.634
(1.350-5.138)
No 4.0% 96.0%
Hypertension Yes 10.2% 89.8% 3.508
(2.218-5.547)
<0.01 2.780
(1.649-4.686)
No 3.1% 96.9%Anagnostopoulos et al. BMC Musculoskeletal Disorders 2010, 11:98
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a prevalence of PsA of 0.42% [23]. Our PsA prevalence
estimate is similar to that reported earlier in Greece
(0.17%) [6].
Our estimate of SLE prevalence (0.11%) is slightly
higher than that reported in a study using medical
records of Hospitals and rheumatology practices in
northwest Greece in 2001 (0.009% for men, 0.069% for
women) [29]. The prevalence of SLE was 0.05% in a study
using physician billing and hospital database in Quebec,
Canada [30], and 0.01% in males and 0.071% in females in
a study using General Practice Research Database in UK
[31]. In northern Spain, a study using database of the sin-
gle Immunology laboratory of a region, found SLE preva-
lence to be 0.034% [32], and in Northern Italy, a study
using hospital medical records reported SLE prevalence
0.058% [33].
The prevalence of pSS in our study (0.23%) is in agree-
ment with those of two previous community-based stud-
ies in Greece [34,35]. In Norway, the prevalence of pSS, as
detected by postal questionnaire, was 0.22% in adult ages
40-44 years and 1.4% in the adult ages 71-74 years [36],
and in UK the prevalence of pSS was 0.33% [37].
Our finding that only one person was diagnosed with
SSc, DM, giant cell arteritis, hypocoplementemic urticar-
ial vasculitis precludes any comment on the prevalence of
these diseases. However, it is worth mentioning that there
are geographical clusters of SSc which suggest an envi-
ronmental aetiology for the disease [3].
The prevalence of gout increases with age, is higher in
men than women, and is on the increase. In adult age >75
years in USA, the prevalence of gout increased from 2.1%
in 1990, to 4.1% in 1999 [38]. The respective values for
men were 2.5%, and 6.4% [38]. In the US National Health
and Nutrition Examination Survey (NHANES) III
between 1988 and 1994, the highest prevalence (8%;
males, 11.6%; females, 5.2%) was found in adult ages 70-
Table 4: Variables assessed for association with osteoarthritis
Variable Osteoarthritis Unadjusted OR P-value Adjusted OR
Yes No (95% CI) 95% c.i.
Gender Male 11.3% 88.7% 0.411
(0.314-0.538)
<0.01 0.430
(0.306-0.604)
Female 23.6% 76.4%
Age ≥66 39.7% 60.3% 265.240
(36.807-1911.358)
<0.01 173.679
(23.714-1271.983)
≥40 & <66 18.4% 81.6% 2.926
(2.220-3.857)
2.140
(1.541-2.974)
<40 0.2% 99.8% Reference Reference
Residence Island 23.8% 76.2% 1.546
(1.113-2.148)
0.033 1.186
(0.810-1.737)
Mountain 18.2% 81.8% 1.397
(0.838-2.329)
1.656
(0.919-2.983)
Urban & suburban 16.8% 83.2% Reference Reference
Alcohol Yes 9.9% 90.1% 0.352
(0.264-0.468)
<0.01 0.827
(0.534-1.283)
No 23.7% 76.3%
Smoke Yes 9.2% 90.8% 0.334
(0.247-0.451)
<0.01 0.667
(0.425-1.045)
No 23.3% 76.7%
Financial problems Yes 20.8% 79.2% 1.353 (1.049-1.745) 0.020 1.316 (0.984-1.759)
No 16.3% 83.7%
Manual work Yes 13.8% 86.2% 0.649
(0.477-0.882)
0.006 1.044
(0.727-1.499)
No 19.8% 80.2%
Diabetes Yes 29.0% 71.0% 2.045 (1.420-2.946) <0.01 0.739 (0.488-1.117)
No 16.7% 83.3%
Hypertension Yes 36.7% 63.3% 3.987 (3.051-5.210) <0.01 2.131 (1.553-2.926)
No 12.7% 87.3%Anagnostopoulos et al. BMC Musculoskeletal Disorders 2010, 11:98
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79 years [39,40]. In a UK study using General Practitioner
database, the prevalence of gout was 0.3% in the 1970s,
and 0.95% in the 1990s [41]. Results from the UK General
Practice database during the period 1990-1999 showed
relatively constant incidence rates. In 1999 the prevalence
of gout was 1.4% in adult population, and 7.0% in males
over 65 years of age [42]. A retrospective study using
medical records of General Practitioners in UK and Ger-
many between 2000 and 2005 found the prevalence of
gout to be 1.4% (mean age, 60 years) [43]. In China, the
prevalence of hyperuricemia and gout varied among dif-
ferent regions. The prevalence of gout was 11.7% in Tai-
wanese aborigines and 3.0% in ethnic Taiwanese [44].
Our estimate of the prevalence of gout is much higher
than that reported in the general Greek population
(0.47%) a few years ago [6]. This may be explained by the
relatively old age of our gouty patients (mean age, 63
years), and the changing diet and lifestyle. High seafood
consumption, which is a risk factor for gout [45], is preva-
lent in this coastal region of Greece. Our study has found
gout to be associated with male gender, hypertension,
and diabetes mellitus. Since hypertension and type II dia-
betes mellitus are components of the metabolic syn-
drome or insulin resistance syndrome, our gouty men are
likely to have this syndrome that carries an increased car-
diovascular risk [46].
Epidemiological studies of OA have inherent problems
due to lack of association between symptoms and radio-
graphic findings that may underestimate OA prevalence.
Generally , the prevalence of O A is associated with age
and is higher in women. The prevalence of symptomatic
hand OA, verified by x-rays, in the Framingham study
was 6.8% (3.8% in men, 9.2% in women) whereas in adults
age > 71 years was 13.4% in men and 26.2% in women
[47]. The prevalence of symptomatic knee OA was 4.9%,
and increased to 6.7% (5.9% in men, 7.2% in women) in
adults aged > 45 years [48]. In the US NHANES III study,
the prevalence of symptomatic knee OA in adults age >60
years was 12.1% [49], and in the Jonston county, northern
Carolina, USA, it was 16.7% in adults age > 45 years [50].
In the latter study, the prevalence of symptomatic hip OA
was 9.2% [40]. In British Columbia, Canada, database
from Health centers and Hospitals between 1991 and
2001 showed a prevalence of symptomatic OA in 2001 of
10.0% in adult ages 45-49 years, whereas 32% of men and
40% of women aged 70 years had OA [51]. In France, a
phone survey in a random population sample of adults
aged 40-75 years found the prevalence of knee OA and
hip OA to be 7.6% and 5%, respectively [52]. In Spain, the
frequency of symptomatic hand OA was 6.2% and knee
OA 10.2% [53]. In our study, there is a low frequency of
hand OA. Individuals with hand OA may have mild
symptoms and do not seek medical advice. Therefore,
these patients did not report their condition. The rela-
tively low prevalence of OA in manual workers, com-
pared to non-manual workers, may be attributed to
women as house-wives. These women, included in non-
manual workers, may have not only house duties but they
may also work manually in the fields, a common practice
in the country. A previous study in Greece showed a
prevalence of symptomatic hand OA of 2.0%, knee OA
6.0%, and hip OA of 0.9% [54].
Radiographic OA, defined by the presence of osteo-
phytes is much prevalent than symptomatic OA. In the
Framingham study, the prevalence of radiographic hand
OA was 27.2% (25.9% in men, 28.2% in women) [47]. The
prevalence of radiographic knee OA was 13.8%, and
increased to 19.2% in the > 45 year-old age group [48]. In
the Jonston county study, the prevalence of radiographic
OA in the >45 year age group was 27.8% (24.3% in men,
30.15% in women) and hip OA was 27.8% [40,50]. In the
US NHANES III study, the prevalence of radiographic
knee OA was 37.4% (31.2% in men, 42.1% in women) in
the > 60 year-old age group [49]. In Holland, radiographic
hand OA was found in 67% of women and 54.8% of men >
55 years of age [55].
As with other studies, our study has limitations to con-
sider. Firstly, our study relied on patient self-reporting of
a physician diagnosis of a disease as opposed to ascertain-
ing a diagnosis through medical records. Additionally,
our study may have missed patients with mild arthritis,
such as OA, that did not come to medical attention. How-
ever, our estimates are generally close to those studies
that used medical records to ascertain rheumatic disease
diagnoses. Furthermore, self-report of chronic disease
has been found accurate [56]. Secondly, our study had a
relatively low response rate. However, similar response
rate has also been reported by other postal surveys [57]
and may be attributed to the increasingly use of question-
naires (postal or by phone) in public marketing.
Conclusions
Rheumatic diseases are common in central Greece,
affecting nearly a quarter of adult population. OA and
gout are the most common joint disorders.
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